Yunnan Energy Investment Co., Ltd. (002053.SZ)
Kunming, CN
Yunnan Energy Investment Co., Ltd., founded in 2002 and based in Kunming, China, specializes in the production and nationwide distribution of a diverse range of salt products. The company's extensive portfolio includes various culinary and consumer salts, such as traditional iodized and non-iodized options, specialized healthy and low-sodium varieties, and unique offerings sourced from plateau deep wells. Beyond kitchen staples, they provide salts for specific uses like pickling, roasting, and industrial applications. Their personal care range features cleansing, daily, bath, foot bath, and hand washing salts, including those infused with essential oils such as rose, lavender, and lemon, alongside gourmet seasoning salts with flavors like wild mushroom or ginger and garlic. Additionally, the company offers personal care items like shampoos and conditioner lotions, as well as pepper, and is involved in the development and construction of natural gas pipelines. The company adopted its current name in August 2016, having previously operated as Yunnan Salt Chemical Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.68% | -0.35% | -1.29% | -3.44% | -3.60% | +0.00% | +3.41% | +7.06% | +46.01% | -6.80% | +79.72% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-28.0% Q1'26: -32.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-64.4% Q1'26: -8.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+27.5% Q1'26: -26.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+16.7% ★ Q1'26: +40.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+2.5% Q1'26: +6.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×7.26× Q1'26: 7.22× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
2.35B
est: 2.27B (+3.5%)
|
2.68B
est: 2.73B (-2.0%)
|
2.90B
est: 3.10B (-6.3%)
|
3.45B
est: 3.61B (-4.4%)
|
2.49B
est: 4.23B (-41.2%)
|
2.70B
2.70B – 2.70B
-36.3% YoY
|
2.97B
2.97B – 2.97B
+10.0% YoY
|
3.18B
3.18B – 3.18B
+7.1% YoY
|
| EBITDA |
664.13M
est: 711.47M (-6.7%)
|
763.23M
est: 856.94M (-10.9%)
|
887.76M
est: 972.51M (-8.7%)
|
1.30B
est: 1.19B (+9.2%)
|
997.00M
est: 1.40B (-28.7%)
|
890.21M
890.21M – 890.21M
-36.3% YoY
|
979.40M
979.40M – 979.40M
+10.0% YoY
|
1.05B
1.05B – 1.05B
+7.1% YoY
|
| EBIT |
364.64M
est: 407.72M (-10.6%)
|
430.15M
est: 491.08M (-12.4%)
|
515.61M
est: 557.31M (-7.5%)
|
801.78M
est: 644.57M (+24.4%)
|
415.02M
est: 755.78M (-45.1%)
|
481.07M
481.07M – 481.07M
-36.3% YoY
|
529.26M
529.26M – 529.26M
+10.0% YoY
|
566.75M
566.75M – 566.75M
+7.1% YoY
|
| Net Income |
249.25M
est: 294.63M (-15.4%)
|
273.92M
est: 331.46M (-17.4%)
|
482.26M
est: 487.99M (-1.2%)
|
675.04M
est: 681.34M (-0.9%)
|
236.30M
est: 929.94M (-74.6%)
|
699.75M
699.75M – 699.75M
-24.8% YoY
|
828.66M
828.66M – 828.66M
+18.4% YoY
|
911.52M
911.52M – 911.52M
+10.0% YoY
|
| SGA |
460.92M
est: 457.64M (+0.7%)
|
572.03M
est: 551.21M (+3.8%)
|
618.13M
est: 625.55M (-1.2%)
|
564.89M
est: 657.27M (-14.1%)
|
307.75M
est: 770.67M (-60.1%)
|
490.54M
490.54M – 490.54M
-36.3% YoY
|
539.69M
539.69M – 539.69M
+10.0% YoY
|
577.91M
577.91M – 577.91M
+7.1% YoY
|
| EPS |
0.33
est: 0.32 (+2.3%)
|
0.30
est: 0.36 (-17.4%)
|
0.52
est: 0.53 (-1.2%)
|
0.73
est: 0.74 (-1.4%)
|
0.26
est: 1.01 (-74.3%)
|
0.76
0.76 – 0.76
-24.8% YoY
|
0.90
0.90 – 0.90
+18.4% YoY
|
0.99
0.99 – 0.99
+10.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.02% | 108.4K | 0.65% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 62.3K | 0.46% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 209.2K | 0.29% |
| 4 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 277.4K | 0.06% |
| 5 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 171.4K | 0.39% |
| 6 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 8.7K | 0.48% |
| 7 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 19.7K | 0.26% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 972.8K | 0.06% |
| 9 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 50.5K | 0.28% |
| 10 | Vanguard Total International Stock ETF VXUS | 0.00% | 1.23M | 0.05% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jianjun Yang | GM & Non-Independent Director | — | male |
| Jin Neng Dai | Accounting Supervisor | — | — |
| Mei Hu Liu | General Counsel & Chief Compliance Officer | — | female |
| Xiao Ying Han | Deputy General Manager | — | female |
| Xifen Liu | Chief Financial Officer & Director | — | female |
| Zhengliang Li | Secretary of the Board & Deputy GM | — | male |
| Zhong Zhao Li | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002053.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
